Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Loading
Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Calendar quarter Q2 2026Earnings call Aug 5, 2026 · most recent call
ZBH’s newest analyzed quarter is part of Tellvest Pro: its score, breakdown, narrative and analyst Q&A. Every prior quarter is free.
Sources. Scores: Zimmer Biomet’s public earnings-call transcripts and SEC-reported results — the base band is anchored to reported GAAP revenue growth; transcript, EPS and guidance adjustments are applied separately (documented exceptions apply to a few issuers). Price: ZBH daily closing prices for the trailing year; dots mark earnings calls, colored by that quarter’s score; the newest quarter’s score is part of Tellvest Pro. How to read a company earnings-call score.
All prior quarters are free. How to browse earnings-call scores without Pro. How to read a company earnings-call score.
The table scrolls sideways. Swipe it, or select it and use the arrow keys.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Gross margin | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|---|
| FY2024 Q4 | $2.02B | +4.3% | $1.20 | -40.3% | 71.0% | 19.2% | 11.8% | $421M |
| FY2025 Q1 | $1.91B | +1.1% | $0.91 | +8.3% | 71.2% | 15.3% | 9.5% | $336M |
| FY2025 Q2 | $2.08B | +7.0% | $0.77 | -34.7% | 71.5% | 14.4% | 7.4% | $298M |
| FY2025 Q3 | $2.00B | +9.7% | $1.16 | -5.7% | 72.1% | 17.6% | 11.5% | $546M |
| FY2025 Q4 | $2.24B | +10.9% | $0.70 | -41.7% | 64.7% | 12.8% | 6.2% | $669M |
| FY2026 Q1 | $2.09B | +9.3% | $1.22 | +34.1% | 72.4% | 17.9% | 11.4% | $323M |
| FY2026 Q2Selected | $2.18B | +4.8% | $1.03 | +33.8% | 70.8% | 15.0% | 9.1% | $484M |
Management-stated figures from ZBH’s newest call are part of Tellvest Pro.
The breakdown for this quarter is part of Tellvest Pro.
Full Pro access for 30 days when you create a free account. No credit card required.
On September 8, 2026, the Company notified Kevin Thornal, Group President, Global Businesses and the Americas, that his position is being restructured and that he will depart the Company effective September 30, 2026. Mr. Thornal will be eligible for severance under the Company's Restated Executive Severance Plan, including a lump sum equal to twelve months of base salary plus target annual bonus and twelve months of COBRA premiums.